Literature DB >> 29991547

A case of posterior reversible encephalopathy syndrome associated with sepsis.

Orlando Garner1, Alfredo Iardino1, Ana Ramirez1.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a neurological disorder characterised by parieto-occipital vasogenic oedema seen on MRI. Infection and sepsis has been reported as a possible cause for this disorder.We present a 19-year-old immunocompetent Caucasian man with known type 1 diabetes mellitus who presented to the emergency department with acute onset of bilateral visual loss, headaches and hypertension; he had been discharged 2 weeks ago for severe diabetic ketoacidosis and Staphylococcus aureus bacteraemia. Initial CT scan of the head was negative, but MRI showed findings suggestive of PRES. He was treated with nicardipine drip for strict blood pressure management and symptoms resolved within 4 days. PRES is a rare disease that has been increasingly reported as MRI becomes more commonplace. Usually associated with immunological disease, pre-eclampsia and cytotoxic therapies but an association with sepsis due to gram-positive bacteria. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  epilepsy and seizures; intensive care; neuroimaging; neurology

Mesh:

Substances:

Year:  2018        PMID: 29991547      PMCID: PMC6047718          DOI: 10.1136/bcr-2018-225128

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  [Posterior reversible encephalopathy syndrome (pres) in sepsis].

Authors:  C de Haro; R Ferrer; A Tercero; J Vallés
Journal:  Med Intensiva       Date:  2012-04-27       Impact factor: 2.491

2.  Posterior reversible encephalopathy syndrome in infection, sepsis, and shock.

Authors:  W S Bartynski; J F Boardman; Z R Zeigler; R K Shadduck; J Lister
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

Review 3.  Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed.

Authors:  V L Stott; M A Hurrell; T J Anderson
Journal:  Intern Med J       Date:  2005-02       Impact factor: 2.048

Review 4.  The posterior reversible encephalopathy syndrome: what's certain, what's new?

Authors:  C Roth; A Ferbert
Journal:  Pract Neurol       Date:  2011-06

Review 5.  Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions.

Authors:  Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Lancet Neurol       Date:  2015-07-13       Impact factor: 44.182

6.  Posterior reversible encephalopathy syndrome: long-term follow-up.

Authors:  Christian Roth; Andreas Ferbert
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-12-01       Impact factor: 10.154

7.  Clinical spectrum of reversible posterior leukoencephalopathy syndrome.

Authors:  Vivien H Lee; Eelco F M Wijdicks; Edward M Manno; Alejandro A Rabinstein
Journal:  Arch Neurol       Date:  2008-02

8.  Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images.

Authors:  Diego J Covarrubias; Patrick H Luetmer; Norbert G Campeau
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

Review 9.  Posterior reversible encephalopathy syndrome.

Authors:  Marlene Fischer; Erich Schmutzhard
Journal:  J Neurol       Date:  2017-01-04       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.